Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.68 |
| ▸ | GAA | P10253 | 9/20 | 0.68 |
| ▸ | MAPT | P10636 | 9/20 | 0.68 |
| ▸ | MEN1 | O00255 | 6/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.68 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | XBP1 | P17861 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7573420 | 0.83 | ALDH1A1 (0.59) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL29838526 | 0.83 | MEN1 (0.62) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL1883671 | 0.83 | MEN1 (0.62) | ALDH1A1GAAMAPTMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL8764180 | 0.81 | MEN1 (0.60) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL20984065 | 0.81 | GAA (0.67) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL10433483 | 0.80 | ALDH1A1 (0.63) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL3267559 | 0.79 | GAA (0.69) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL11207257 | 0.78 | ALDH1A1 (0.63) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL12188088 | 0.77 | ALDH1A1 (0.55) | ALDH1A1GAAMAPTMEN1KMT2A | |
| Aziridine SCHEMBL29221601 | 0.76 | MAPT (0.55) | ALDH1A1GAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140248291-A1 | Modulation of Cellular Migration | THE UAB RESEARCH FOUNDATION (US) | 2014-09-04 | — | — | US | disclosed |
| EP-2105433-B1 | Modular scaffold for the design of specific molecules for the use as peptidomimetics and inhibitors of protein interaction | UNIV DRESDEN TECH (DE) | 2010-09-22 | — | — | EP | disclosed |
| EP-2105433-A1 | Modular scaffold for the design of specific molecules for the use as peptidomimetics and inhibitors of protein interaction | Technische Universität Dresden (DE) | 2009-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140248291-A1 | Modulation of Cellular Migration | BDKRB2, BDKRB1, PTGIR | ALDH1A1 4717/4885GAA 4847/4885MAPT 4153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.